Business
Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business
WALTHAM, Mass., September 02, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, today announced the completion of its acquisition of the Purification & Filtration business of Solventum (NYSE: SOLV) for approximately $4.0 billion in cash. With the transaction complete, the business, which is now Thermo Fisher’s Filtration and Separation business, is part of the Life Sciences Solutions segment.
About this update from Thermo Fisher Scientific Inc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1590,"height":341,"url":"https://media.zenfs.com/en/business-wire.com/e57e300525592e1ede186eb0e72e7206"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/foZ6kH3SE5pm8iwjKE6ZAQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIwNjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/e57e300525592e1ede186eb0e72e7206","width":960,"height":206},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/KmEGZuHPjD7f7Y7E4qEJZg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MTQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/e57e300525592e1ede186eb0e72e7206","width":1200,"height":257}},"lazy":false},{"type":"text","content":"Highly Complementary Technologies Strengthen Thermo Fisher’s Portfolio in Bioprocessing and Adjacent Markets","length":108,"tagName":"p","attribs":{}},{"type":"text","content":"WALTHAM, Mass., September 02, 2025--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, today announced the completion of its acquisition of the Purification & Filtration business of Solventum (NYSE: SOLV) for approximately $4.0 billion in cash. With the transaction complete, the business, which is now Thermo Fisher’s Filtration and Separation business, is part of the Life Sciences Solutions segment.","length":480,"tagName":"p"},{"type":"text","content":"The transaction includes Solventum’s Purification & Filtration business serving Bioprocessing Filtration, Healthcare and Industrial Filtration, and Membranes1. The business strengthens Thermo Fisher’s bioproduction offerings with advanced filtration technologies that improve quality and efficiency across upstream and downstream workflows. In addition, its robust industrial filtration and membrane solutions will expand our reach into industries requiring ultra-pure water, including battery, semiconductor and medical device manufacturing. For the full year 2025, the business is expected to generate approximately $750 million of revenue.","length":646,"tagName":"p"},{"type":"text","content":""We are delighted to welcome the Filtration and Separation colleagues to Thermo Fisher," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. "The addition of inn...